Rare case of endogenous Klebsiella endophthalmitis associated with emphysematous prostatitis in a patient with diabetes, cirrhosis and COVID-19.
Alexander B CraneMonica C Abreu DiazYi JiangKathleen Mangunay PergamentPublished in: BMJ case reports (2021)
A 35-year-old Hispanic man presented with fever, chills, dysuria, diarrhoea, scleral icterus, tachycardia and tachypnea. He was found to be COVID-19 positive, CT of the pelvis revealed prostatic abscess, and urine culture grew Klebsiella pneumoniae Additionally, he was found to have diabetes and cirrhosis. During treatment, the patient developed vision loss, and was diagnosed with endogenous Klebsiella endophthalmitis. The patient was treated with intravenous antibiotics, pars plana vitrectomy, intravitreal antibiotics and cystoscopy/suprapubic catheter placement. On follow-up, the patient has had the suprapubic catheter removed, and successfully passed a voiding trial, but suffers permanent vision loss in both eyes.
Keyphrases
- case report
- coronavirus disease
- klebsiella pneumoniae
- rare case
- type diabetes
- sars cov
- computed tomography
- multidrug resistant
- escherichia coli
- clinical trial
- diabetic retinopathy
- glycemic control
- ultrasound guided
- insulin resistance
- metabolic syndrome
- adipose tissue
- study protocol
- atrial fibrillation
- low dose
- contrast enhanced
- open label
- positron emission tomography
- cataract surgery
- benign prostatic hyperplasia
- phase ii
- endothelial cells
- dual energy
- double blind
- placebo controlled